ARCHIVES

In Setback For Generics, Court Overturns FDA.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

NCI’s Share Of Gramm-Rudman Cuts For FY 1986 Is $54 Million; Staff Ponders How To Absorb It

January 24, 1986

NSABP Protests NIH Rejection Of P-4 Appeal.

May 2, 2008

Central Europe Faces Massive Public Education, Environmental Problems, Related To Cancer

August 23, 1991

NCI, USSR Agree On New Collaborative Cancer Control Studies

June 20, 1975

NCI Committee Attempts To Redesign Cooperative Groups Without Doing Harm

June 12, 1998

Herberman Leaving NCI To Head New Pittsburgh Institute

July 12, 1985